Company / Current Liabilities per Share
Viking Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.69
FY2025
5-year range
$0.12 / $0.69
FY2021-FY2025
Trend
+150.9%
vs FY2024
Sector context
#134 of 210
Health Care
What the data says
At $0.69, Viking Therapeutics, Inc.'s current liabilities per share ranks #77 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2019 to $0.69 in FY2025.
Based on SEC 10-K filings.
0.69 in FY2025 with a 5-year CAGR of +32.6%.
Increased from $0.24 to $0.69 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +34.8%
- 5-Year CAGR
- +32.6%
- 10-Year CAGR
- -
Sector benchmark
-97.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 150.9% year-over-year.
- Ranks #134 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | +150.9% |
| FY2024 | $0.27 | +12.0% |
| FY2023 | $0.24 | -12.8% |
| FY2022 | $0.28 | +133.9% |
| FY2021 | $0.12 | -28.4% |
| FY2020 | $0.17 | +77.3% |
| FY2019 | $0.09 | -25.6% |
| FY2018 | $0.13 | -69.4% |
| FY2017 | $0.42 | -37.8% |
| FY2016 | $0.67 | +103.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026